A protective role of complement component 3 in T cell-mediated skin inflammation

2011 ◽  
Vol 20 (9) ◽  
pp. 709-714 ◽  
Author(s):  
Rahul Purwar ◽  
Wolfgang Bäumer ◽  
Margarete Niebuhr ◽  
Thomas Tschernig ◽  
Manfred Kietzmann ◽  
...  
Author(s):  
Kristen Orumaa ◽  
Margaret R. Dunne

AbstractCOVID-19 is a respiratory disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It was first documented in late 2019, but within months, a worldwide pandemic was declared due to the easily transmissible nature of the virus. Research to date on the immune response to SARS-CoV-2 has focused largely on conventional B and T lymphocytes. This review examines the emerging role of unconventional T cell subsets, including γδ T cells, invariant natural killer T (iNKT) cells and mucosal associated invariant T (MAIT) cells in human SARS-CoV-2 infection.Some of these T cell subsets have been shown to play protective roles in anti-viral immunity by suppressing viral replication and opsonising virions of SARS-CoV. Here, we explore whether unconventional T cells play a protective role in SARS-CoV-2 infection as well. Unconventional T cells are already under investigation as cell-based immunotherapies for cancer. We discuss the potential use of these cells as therapeutic agents in the COVID-19 setting. Due to the rapidly evolving situation presented by COVID-19, there is an urgent need to understand the pathogenesis of this disease and the mechanisms underlying its immune response. Through this, we may be able to better help those with severe cases and lower the mortality rate by devising more effective vaccines and novel treatment strategies.


2020 ◽  
Vol 85 ◽  
pp. 106692
Author(s):  
Quan-you Zheng ◽  
Shen-ju Liang ◽  
Feng Xu ◽  
Yi Yang ◽  
Jian-li Feng ◽  
...  

Blood ◽  
2013 ◽  
Vol 121 (10) ◽  
pp. 1760-1768 ◽  
Author(s):  
Ching-Chuan Hsieh ◽  
Hong-Shiue Chou ◽  
Horng-Ren Yang ◽  
Feng Lin ◽  
Sumantha Bhatt ◽  
...  

Key Points C3 and MDSC development


2015 ◽  
Vol 194 (10) ◽  
pp. 4631-4640 ◽  
Author(s):  
Takashi Hashimoto ◽  
Takahiro Satoh ◽  
Hiroo Yokozeki

PLoS ONE ◽  
2018 ◽  
Vol 13 (7) ◽  
pp. e0201139 ◽  
Author(s):  
Mian Zhou ◽  
Monowar Aziz ◽  
Manhendar Ochani ◽  
Weng-Lang Yang ◽  
Archna Sharma ◽  
...  

2012 ◽  
Vol 302 (11) ◽  
pp. F1503-F1515 ◽  
Author(s):  
Jan-Eric Turner ◽  
Hans-Joachim Paust ◽  
Sabrina B. Bennstein ◽  
Phillip Bramke ◽  
Christian Krebs ◽  
...  

Leukocyte infiltration is a characteristic feature of human and experimental lupus nephritis and is closely correlated with loss of renal function. The chemokine receptor CCR5 is expressed on monocyte and T cell subsets and is thought to play an important role in recruiting these cells into inflamed organs. To investigate the functional role of CCR5 in lupus nephritis, CCR5-deficient mice were backcrossed onto the lupus-prone MRL- Faslpr (MRL/lpr) genetic background. Unexpectedly, CCR5−/− MRL/lpr mice developed an aggravated course of lupus nephritis in terms of glomerular tissue injury and albuminuria. Deterioration of the nephritis was associated with an overall increase in mononuclear cell infiltration into the kidney, whereas renal leukocyte subtype balance, systemic T cell response, and autoantibody formation were unaffected by CCR5 deficiency. Renal and systemic protein levels of the CCR5 ligand CCL3, which can also attract leukocytes via its alternate receptor CCR1, were significantly increased in nephritic CCR5−/− MRL/lpr mice. Further studies revealed that the systemic increase in the CCR5/CCR1 ligand is also observed in nonimmune CCR5−/− C57BL/6 mice and that this increase was due to a reduced clearance, rather than an overproduction, of CCL3. Taken together, our data support the hypothesis that CCR5-dependent consumption of its own ligands may act as a negative feedback loop to restrain local chemokine levels within inflamed tissues, thereby limiting inflammatory cell influx.


Biomedicines ◽  
2021 ◽  
Vol 9 (1) ◽  
pp. 58
Author(s):  
Laura Elisa Buitrago-Molina ◽  
Janine Dywicki ◽  
Fatih Noyan ◽  
Martin Trippler ◽  
Julia Pietrek ◽  
...  

Autoimmune hepatitis (AIH) is detected at a late stage in the course of the disease. Therefore, induction and etiology are largely unclear. It is controversial if the induction of autoimmunity occurs in the liver or in the spleen. In our experimental murine AIH model, the induction of autoimmunity did not occur in the spleen. Instead, a protective role of the spleen could be more likely. Therefore, we splenectomized mice followed by induction of experimental murine AIH. Splenectomized mice presented more severe portal inflammation. Furthermore, these mice had more IL-17, IL-23 receptor (IL-23R) and caspase 3 (casp3) and a decreased amount of erythropoietin in serum, while intrahepatic T cell compartments were unaffected. These results indicate that the spleen is not necessary for induction of AIH, and splenectomy disrupts the ability to immune regulate the intensity of hepatic inflammation, production of IL-17 and apoptosis.


Sign in / Sign up

Export Citation Format

Share Document